[go: up one dir, main page]

FI953002A7 - Menetelmä kroonisen eturauhastulehduksen hoitamiseksi 17beta-N-monosub stituoiduilla karbamoyyli-4-atsa-5alfa-androst-1-en-3-oneilla - Google Patents

Menetelmä kroonisen eturauhastulehduksen hoitamiseksi 17beta-N-monosub stituoiduilla karbamoyyli-4-atsa-5alfa-androst-1-en-3-oneilla Download PDF

Info

Publication number
FI953002A7
FI953002A7 FI953002A FI953002A FI953002A7 FI 953002 A7 FI953002 A7 FI 953002A7 FI 953002 A FI953002 A FI 953002A FI 953002 A FI953002 A FI 953002A FI 953002 A7 FI953002 A7 FI 953002A7
Authority
FI
Finland
Prior art keywords
5alpha
17beta
androst
aza
ones
Prior art date
Application number
FI953002A
Other languages
English (en)
Swedish (sv)
Other versions
FI953002A0 (fi
FI953002L (fi
Inventor
Glenn J Gormley
Elizabeth Stoner
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of FI953002A7 publication Critical patent/FI953002A7/fi
Publication of FI953002A0 publication Critical patent/FI953002A0/fi
Publication of FI953002L publication Critical patent/FI953002L/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI953002A 1992-12-18 1993-11-18 Menetelmä kroonisen eturauhastulehduksen hoitamiseksi 17beta-N-monosubstituoiduilla karbamoyyli-4-atsa-5alfa-androst-1-en-3-oneilla FI953002L (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US99298592A 1992-12-18 1992-12-18
PCT/US1993/011155 WO1994014452A1 (en) 1992-12-18 1993-11-18 METHOD OF TREATMENT OF CHRONIC PROSTATITIS WITH 17β-N-MONOSUBSTITUTED-CARBAMOYL-4-AZA-5α-ANDROST-1-EN-3-ONES

Publications (3)

Publication Number Publication Date
FI953002A7 true FI953002A7 (fi) 1995-06-16
FI953002A0 FI953002A0 (fi) 1995-06-16
FI953002L FI953002L (fi) 1995-06-16

Family

ID=25538974

Family Applications (1)

Application Number Title Priority Date Filing Date
FI953002A FI953002L (fi) 1992-12-18 1993-11-18 Menetelmä kroonisen eturauhastulehduksen hoitamiseksi 17beta-N-monosubstituoiduilla karbamoyyli-4-atsa-5alfa-androst-1-en-3-oneilla

Country Status (17)

Country Link
US (1) US5629318A (fi)
EP (1) EP0674521B1 (fi)
JP (1) JPH08504813A (fi)
AT (1) ATE203162T1 (fi)
AU (1) AU691164B2 (fi)
CA (1) CA2151239A1 (fi)
CZ (1) CZ285379B6 (fi)
DE (1) DE69330465T2 (fi)
DK (1) DK0674521T3 (fi)
ES (1) ES2158887T3 (fi)
FI (1) FI953002L (fi)
GR (1) GR3036241T3 (fi)
HU (1) HU220064B (fi)
NO (1) NO308829B1 (fi)
NZ (1) NZ258435A (fi)
PT (1) PT674521E (fi)
WO (1) WO1994014452A1 (fi)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3993899A (en) * 1998-05-18 1999-12-06 Merck & Co., Inc. Method for treating or preventing chronic nonbacterial prostatitis and prostatodynia
US6645974B2 (en) 2001-07-31 2003-11-11 Merck & Co., Inc. Androgen receptor modulators and methods for use thereof
US7101847B2 (en) * 2002-10-11 2006-09-05 Milkhaus Laboratory, Inc. Method of treating chronic pelvic pain syndrome by administration of chorionic gonadotropin
JP2007505120A (ja) * 2003-09-10 2007-03-08 メルク　エンド　カムパニー　インコーポレーテッド アンドロゲン受容体調節因子としての１７−複素環式−４−アザステロイド誘導体。
JP2007509962A (ja) * 2003-10-31 2007-04-19 メルク　エンド　カムパニー　インコーポレーテッド アンドロゲン受容体調節剤としての２１−複素環−４−アザステロイド誘導体
US20080268463A1 (en) * 2007-03-07 2008-10-30 Children's Medical Center Corporation Methods for Prognosis and Diagnosis of Chronic Prostatitis/Pelvic Pain Syndrome and Interstitial Cystitis
RU2525182C1 (ru) * 2013-02-28 2014-08-10 Государственное бюджетное образовательное учреждение высшего профессионального образования Первый Московский государственный медицинский университет им. И.М. Сеченова Министерства здравоохранения Российской Федерации (ГБОУ ВПО Первый МГМУ им. И.М. Сеченова Минздрава России) Способ лечения больных хроническим простатитом с парциальным андрогенодефицитом
CN104161739B (zh) * 2014-08-15 2017-09-19 武汉人福药业有限责任公司 非那雄胺胶囊及其制备方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2227876A (en) * 1937-10-16 1941-01-07 Firm Of N V Organon Steroid derivatives with nuclear substituted nitrogen
US3285918A (en) * 1962-04-18 1966-11-15 Norman J Doorenbos 1', 4', 5', 6'-tetrahydropyrimidino[a-4, 3]-4-aza-5-cholestene
US3239417A (en) * 1962-12-07 1966-03-08 Smith Kline French Lab Methods and compositions for inhibiting sterol biosynthesis
US3264301A (en) * 1963-08-22 1966-08-02 Norman J Doorenbos Substituted-4-azasteroids
FR1465544A (fr) * 1965-11-29 1967-01-13 Roussel Uclaf Dérivés stéroïdes aromatiques substitués par un atome d'azote endocyclique et procédé de préparation
US4377584A (en) * 1978-04-13 1983-03-22 Merck & Co., Inc. 4-Aza-17β-substituted-5α-androstan-3-one-reductase inhibitors
US4220775A (en) * 1979-03-15 1980-09-02 Merck & Co., Inc. Preparation of 4-aza-17-substituted-5α-androstan-3-ones useful as 5α-reductase inhibitors
US5049562A (en) * 1984-02-27 1991-09-17 Merck & Co., Inc. 17β-acyl-4-aza-5α-androst-1-ene-3-ones as 5α-reductase inhibitors
US4760071A (en) * 1984-02-27 1988-07-26 Merck & Co., Inc. 17β-N-monosubstituted carbamoyl-4-aza-5α-androst-1-en-3-ones which are active as testosterone 5α-reductase inhibitors
US4859681A (en) * 1984-02-27 1989-08-22 Merck & Co., Inc. 17 α-Acyl-4-aza-5a-androst-1-en-3-ones as 5 alpha-reductase inhibitors
US4845104A (en) * 1986-11-20 1989-07-04 Merck & Co., Inc. Oxidized analogs of 17β-N-monosubstituted-carbamoyl-4-aza-5-α-androstan-3-ones
EP0285383B1 (en) * 1987-04-03 1994-03-16 Merck & Co. Inc. Treatment of prostatic carcinoma with 17beta-n-monosubstituted-carbamoyl-4-aza-5alpha-androst-1-en-3-ones
US4946688A (en) * 1988-07-05 1990-08-07 Fahim Mostafa S Intraprostatic injection of zinc ions for treatment of inflammatory conditions and benign and malignant tumors of the prostate
DK627289D0 (da) * 1989-12-12 1989-12-12 Per C Oden Anvendelse af bicyclononanderivater
US5175155A (en) * 1991-10-07 1992-12-29 Sterling Winthrop Inc. Win 49596-finasteride method of use and compositions
AU4251993A (en) * 1992-05-20 1993-12-13 Merck & Co., Inc. Substituted 4-aza-5A-androstan-ones as 5A-reductase inhibitors
WO1993023420A1 (en) * 1992-05-20 1993-11-25 Merck & Co., Inc. NEW 7β-SUBSTITUTED-4-AZA-5α-ANDROSTAN-3-ONES AS 5α-REDUCTASE INHIBITORS
GB9216284D0 (en) * 1992-07-31 1992-09-16 Erba Carlo Spa Fluorinated 17beta-substituted 4-aza-5alpha-androstane-3-one derivatives
WO1994007861A1 (en) * 1992-10-06 1994-04-14 Merck & Co., Inc. 17β-CARBOXANILIDES OF 4-AZA-5α-ANDROSTAN-3-ONES AS 5α-REDUCTASE INHIBITORS

Also Published As

Publication number Publication date
ES2158887T3 (es) 2001-09-16
NO952427D0 (no) 1995-06-16
EP0674521A1 (en) 1995-10-04
DE69330465T2 (de) 2002-04-25
NO308829B1 (no) 2000-11-06
HU9501777D0 (en) 1995-08-28
CZ157795A3 (en) 1995-11-15
DE69330465D1 (de) 2001-08-23
PT674521E (pt) 2001-10-31
US5629318A (en) 1997-05-13
DK0674521T3 (da) 2001-09-24
NZ258435A (en) 1997-05-26
CA2151239A1 (en) 1994-07-07
EP0674521A4 (en) 1998-02-04
FI953002A0 (fi) 1995-06-16
FI953002L (fi) 1995-06-16
JPH08504813A (ja) 1996-05-28
ATE203162T1 (de) 2001-08-15
WO1994014452A1 (en) 1994-07-07
EP0674521B1 (en) 2001-07-18
HUT73231A (en) 1996-07-29
CZ285379B6 (cs) 1999-07-14
HU220064B (hu) 2001-10-28
AU691164B2 (en) 1998-05-14
AU5610594A (en) 1994-07-19
NO952427L (no) 1995-06-16
GR3036241T3 (en) 2001-10-31

Similar Documents

Publication Publication Date Title
FI935922A7 (fi) Menetelmä jäteveden käsittelemiseksi
FI944619A7 (fi) Aldolisointi-dehydratointimenetelmä
FI961430L (fi) Prosessi I
DE69329610D1 (de) Zugriffsverfahren
DE69414001D1 (de) Bestimmungsmethode
FI934428A7 (fi) Menetelmä kuitujen sijoittamiseksi
DE4392789T1 (de) System zum Behandeln von Übergangszonenmaterialien
FI935846L (fi) Jauhamismenetelmä
FI961431L (fi) Prosessi II
FI932871L (fi) Stereoselektiv anjonglykosylationsprocess
FI925357L (fi) Rakennusmenetelmä
DE69328524D1 (de) Exonuklease-Dekontaminierungsverfahren
FI921621L (fi) Sprutmetod foer braensle
FI953002A7 (fi) Menetelmä kroonisen eturauhastulehduksen hoitamiseksi 17beta-N-monosub stituoiduilla karbamoyyli-4-atsa-5alfa-androst-1-en-3-oneilla
FI944236A7 (fi) Migreenin hoitomenetelmä
DK96392D0 (da) Modifikationsmetode
DE59302523D1 (de) Antriebsschlupfregelverfahren
FI954519L (fi) Vaunu
DE59301337D1 (de) Antriebsschlupfregelverfahren
FI950882A7 (fi) Menetelmä prosessiveden käsittelemiseksi
DE69333165D1 (de) Elektrophoresevorrichtung
FI944562L (fi) Vaunut
EE9400450A (et) Meetod detailide töötlemiseks
DE69309870D1 (de) Drehverfahren
FI931051A7 (fi) Kuvausmenetelmä

Legal Events

Date Code Title Description
FD Application lapsed